1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Dicerna Pharmaceuticals Inc (DRNA)
  7. Quote


Dicerna Pharmaceuticals Stock Price

0.07 (0.18%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 3,944,536
Bid Price 38.08
Ask Price 38.25
News -
Day High 38.265


52 Week Range


Day Low 38.06
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Dicerna Pharmaceuticals Inc DRNA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.07 0.18% 38.19 20:00:01
Open Price Low Price High Price Close Price Prev Close
38.18 38.06 38.265 38.25 38.12
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
30,043 3,944,536 $ 38.15 $ 150,478,195 - 19.06 - 40.14
Last Trade Time Type Quantity Stock Price Currency
19:09:50 formt 200 $ 38.19 USD


Draw Mode:

Dicerna Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.98B 77.91M 74.68M $ 164.31M $ -105.37M -1.52 -23.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -24.95k 0.40%

more financials information »

Dicerna Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical DRNA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week37.9338.26537.9338.056,946,3870.260.69%
1 Month22.4438.26520.8737.015,533,15415.7570.19%
3 Months21.8738.26519.0633.632,259,84016.3274.62%
6 Months30.157340.1419.0632.061,573,4208.0326.64%
1 Year24.5340.1419.0630.171,172,92013.6655.69%
3 Years15.1140.149.3124.28774,54923.08152.75%
5 Years3.1240.142.42121.18608,02735.071,124.04%

Dicerna Pharmaceuticals Description

Dicerna Pharmaceuticals is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, cardiovascular diseases, cancers, and other liver problems. The company uses its ribonucleic acid interference technology platform to develop its products. In addition, Dicerna's proprietary GalXC technology focuses on silencing disease-causing genes. The product candidates are nedosiran (for primary hyperoxaluria), belcesiran (for genetic liver disease), DCR-PCSK9 (for cardiovascular disease), and RG6346 (for hepatitis B virus) among others. Dicerna generates revenue by forming collaborative relationships with pharmaceutical companies such as Eli Lilly, Roche, Novo Nordisk, and others.

Your Recent History
Dicerna Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.